UCB Ventures is a €150 million corporate venture fund focused on Series A investments. They typically invest in technologies related to mobile, health, biotech, and deep tech, with investment amounts ranging from €0 to €20 million. Notable companies funded include ViaNautis, Splice Bio, and Bingli. UCB Ventures aims to support promising startups through financial resources and strategic guidance.
